Genus (LON:GNS – Free Report) had its price target lifted by Shore Capital from GBX 2,900 to GBX 3,000 in a research note published on Wednesday, MarketBeat reports. Shore Capital currently has a buy rating on the stock.
Separately, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Genus from GBX 2,550 to GBX 2,900 and gave the company a “buy” rating in a research report on Monday, September 15th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Genus currently has an average rating of “Buy” and an average target price of GBX 3,050.
View Our Latest Stock Analysis on GNS
Genus Price Performance
Genus (LON:GNS – Get Free Report) last issued its quarterly earnings data on Thursday, September 4th. The company reported GBX 81.80 EPS for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, research analysts forecast that Genus will post 70.9644323 earnings per share for the current fiscal year.
Insider Activity at Genus
In related news, insider Jorgen Kokke sold 3,450 shares of Genus stock in a transaction on Thursday, September 25th. The shares were sold at an average price of GBX 2,332, for a total value of £80,454. Corporate insiders own 0.70% of the company’s stock.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
See Also
- Five stocks we like better than Genus
- What is the MACD Indicator and How to Use it in Your Trading
- Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger
- Best Stocks Under $5.00
- MarketBeat Week in Review – 11/17 – 11/21
- 3 Dividend Kings To Consider
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
